$CBDY
Target Group Inc.

2024 Q4 Form 10-Q Financial Statement

#000141057824001793 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $541.1K $1.046M
YoY Change -48.28%
Cost Of Revenue $173.0K $454.2K
YoY Change -61.91%
Gross Profit $368.1K $592.0K
YoY Change -37.82%
Gross Profit Margin 68.03% 56.58%
Selling, General & Admin $380.0K
YoY Change 11.55%
% of Gross Profit 64.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $206.6K $237.8K
YoY Change -13.1% 7.89%
% of Gross Profit 56.13% 40.17%
Operating Expenses $605.9K $648.5K
YoY Change -6.57% 132.84%
Operating Profit -$237.8K -$56.50K
YoY Change 320.83%
Interest Expense $337.7K
YoY Change 25.48%
% of Operating Profit
Other Income/Expense, Net -$291.2K -$300.3K
YoY Change -3.04% 490.11%
Pretax Income -$529.0K -$356.8K
YoY Change 48.24% 24.69%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$529.0K -$356.8K
YoY Change 48.24% 24.69%
Net Earnings / Revenue -97.75% -34.1%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 617.0M 617.0M 617.0M
Diluted Shares Outstanding 617.0M 617.0M

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $450.0K
YoY Change 127.61%
Cash & Equivalents $1.293M $453.9K
Short-Term Investments
Other Short-Term Assets $50.00K
YoY Change -91.08%
Inventory $1.010M $1.893M
Prepaid Expenses $41.86K $41.79K
Receivables $46.23K $128.2K
Other Receivables $70.00K
Total Short-Term Assets $2.592M $2.585M
YoY Change 0.25% 199.59%
LONG-TERM ASSETS
Property, Plant & Equipment $4.686M $5.428M
YoY Change -13.67% -4.74%
Goodwill $264.0K $263.6K
YoY Change 0.16% -92.26%
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets
YoY Change
Total Long-Term Assets $4.993M $5.742M
YoY Change -13.04% -41.05%
TOTAL ASSETS
Total Short-Term Assets $2.592M $2.585M
Total Long-Term Assets $4.993M $5.742M
Total Assets $7.585M $8.327M
YoY Change -8.91% -21.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $530.0K
YoY Change -88.09%
Accrued Expenses $2.270M
YoY Change 54.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due $7.721M $2.126M
YoY Change 263.2% 15.59%
Total Short-Term Liabilities $13.49M $8.411M
YoY Change 60.41% 31.83%
LONG-TERM LIABILITIES
Long-Term Debt $5.583M
YoY Change -3.17%
Other Long-Term Liabilities $1.230M
YoY Change -7.64%
Total Long-Term Liabilities $1.090M $6.771M
YoY Change -83.91% -3.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.49M $8.411M
Total Long-Term Liabilities $1.090M $6.771M
Total Liabilities $14.58M $15.18M
YoY Change -3.96% 13.42%
SHAREHOLDERS EQUITY
Retained Earnings -$31.16M -$30.92M
YoY Change 0.78% 15.12%
Common Stock $61.70K $61.70K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.997M -$6.855M
YoY Change
Total Liabilities & Shareholders Equity $7.585M $8.327M
YoY Change -8.91% -21.46%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$529.0K -$356.8K
YoY Change 48.24% 24.69%
Depreciation, Depletion And Amortization $206.6K $237.8K
YoY Change -13.1% 7.89%
Cash From Operating Activities -$570.0K
YoY Change -541.96%
INVESTING ACTIVITIES
Capital Expenditures $10.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$10.00K
YoY Change -119.94%
Cash From Investing Activities -$10.00K
YoY Change -119.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -570.0K
Cash From Investing Activities -10.00K
Cash From Financing Activities 0.000
Net Change In Cash -580.0K
YoY Change -701.1%
FREE CASH FLOW
Cash From Operating Activities -$570.0K
Capital Expenditures $10.00K
Free Cash Flow -$580.0K
YoY Change -549.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Other Receivable After Allowance For Credit Loss Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q4 us-gaap Accounts Payable Current Related Party Type Extensible Enumeration
AccountsPayableCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q3 us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q3 us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
dei Entity Central Index Key
EntityCentralIndexKey
0001586554
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Trading Symbol
TradingSymbol
CBDY
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
617025999
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
617025999
CY2024Q3 us-gaap Other Receivable After Allowance For Credit Loss Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q3 us-gaap Accounts Payable Current Related Party Type Extensible Enumeration
AccountsPayableCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q3 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q3 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q2 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55066
dei Entity Registrant Name
EntityRegistrantName
TARGET GROUP INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3621499
dei Entity Address Address Line1
EntityAddressAddressLine1
20 Hempstead Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Hamilton
dei Entity Address City Or Town
EntityAddressCityOrTown
Ontario
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
L8W 2E7
dei City Area Code
CityAreaCode
1 905
dei Local Phone Number
LocalPhoneNumber
541-3833
dei Security12g Title
Security12gTitle
Common Stock, Par Value $0.0001
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
617025999
CY2024Q3 us-gaap Cash
Cash
1284480
CY2023Q4 us-gaap Cash
Cash
736323
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
8520
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
8696
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
46229
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1031530
CY2024Q3 us-gaap Inventory Net
InventoryNet
1010292
CY2023Q4 us-gaap Inventory Net
InventoryNet
1215928
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
41855
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
42720
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent
103712
CY2024Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
8864
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
55268
CY2024Q3 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
84205
CY2024Q3 us-gaap Other Receivables
OtherReceivables
3704
CY2023Q4 us-gaap Other Receivables
OtherReceivables
3781
CY2024Q3 us-gaap Assets Current
AssetsCurrent
2591861
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3094246
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4686306
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5430260
CY2024Q3 us-gaap Goodwill
Goodwill
264008
CY2023Q4 us-gaap Goodwill
Goodwill
269460
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
42858
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
46936
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
4993172
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
5746656
CY2024Q3 us-gaap Assets
Assets
7585033
CY2023Q4 us-gaap Assets
Assets
8840902
CY2024Q3 us-gaap Bank Overdrafts
BankOverdrafts
506
CY2023Q4 us-gaap Bank Overdrafts
BankOverdrafts
506
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2836129
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2945568
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
42226
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
43098
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
48581
CY2024Q3 cbdy Related Party Payables Net Current
RelatedPartyPayablesNetCurrent
10461829
CY2023Q4 cbdy Related Party Payables Net Current
RelatedPartyPayablesNetCurrent
11415557
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
142943
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
127478
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
480
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
480
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
7974
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
8021
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13492087
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14589289
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1089193
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1223955
CY2024Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
414
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
355
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1089607
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1224310
CY2024Q3 us-gaap Liabilities
Liabilities
14581694
CY2023Q4 us-gaap Liabilities
Liabilities
15813599
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
100
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
100
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
61703
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
61703
CY2024Q3 cbdy Shares To Be Issued Total
SharesToBeIssuedTotal
175439
CY2023Q4 cbdy Shares To Be Issued Total
SharesToBeIssuedTotal
175439
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24985697
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24985697
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31162802
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31107348
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1056798
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1088288
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-6996661
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-6972697
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7585033
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8840902
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
541113
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1046227
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4736055
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1805211
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
173006
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
454241
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2088954
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
823502
CY2024Q3 us-gaap Gross Profit
GrossProfit
368107
CY2023Q3 us-gaap Gross Profit
GrossProfit
591986
us-gaap Gross Profit
GrossProfit
2647101
us-gaap Gross Profit
GrossProfit
981709
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
40730
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
31779
us-gaap Professional Fees
ProfessionalFees
183244
us-gaap Professional Fees
ProfessionalFees
47885
CY2024Q3 us-gaap Management Fee Expense
ManagementFeeExpense
75831
CY2023Q3 us-gaap Management Fee Expense
ManagementFeeExpense
78352
us-gaap Management Fee Expense
ManagementFeeExpense
263365
us-gaap Management Fee Expense
ManagementFeeExpense
233867
cbdy Salary And Wage Nonofficer
SalaryAndWageNonofficer
53083
CY2024Q3 us-gaap Legal Fees
LegalFees
32067
CY2023Q3 us-gaap Legal Fees
LegalFees
27799
us-gaap Legal Fees
LegalFees
150152
us-gaap Legal Fees
LegalFees
231726
CY2024Q3 us-gaap Depreciation
Depreciation
206628
CY2023Q3 us-gaap Depreciation
Depreciation
237789
us-gaap Depreciation
Depreciation
646290
us-gaap Depreciation
Depreciation
680043
CY2024Q3 cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
-56286
CY2023Q3 cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
-119729
cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
-165896
cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
-137039
CY2024Q3 cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-194356
CY2023Q3 cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-153041
cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-456273
cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-212172
CY2024Q3 cbdy Travel Expenses
TravelExpenses
-10
cbdy Travel Expenses
TravelExpenses
7352
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
605888
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
648489
us-gaap Operating Expenses
OperatingExpenses
1872572
us-gaap Operating Expenses
OperatingExpenses
1489649
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
8427
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-8988
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-14
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-10314
CY2024Q3 cbdy Gain Loss On Settlement Of Liability
GainLossOnSettlementOfLiability
-50
cbdy Gain Loss On Settlement Of Liability
GainLossOnSettlementOfLiability
36758
cbdy Gain Loss On Settlement Of Liability
GainLossOnSettlementOfLiability
1428185
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
268186
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
337675
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
890572
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1060373
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-31194
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
50995
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
40351
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
201
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
8796
us-gaap Investment Income Interest
InvestmentIncomeInterest
8796
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
16782
CY2024Q3 cbdy Allowance Recovery For Sales Tax Recoverable
AllowanceRecoveryForSalesTaxRecoverable
3338
CY2023Q3 cbdy Allowance Recovery For Sales Tax Recoverable
AllowanceRecoveryForSalesTaxRecoverable
7868
cbdy Allowance Recovery For Sales Tax Recoverable
AllowanceRecoveryForSalesTaxRecoverable
11558
cbdy Allowance Recovery For Sales Tax Recoverable
AllowanceRecoveryForSalesTaxRecoverable
7868
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
24152
CY2024Q3 cbdy Debt Issuance Costs
DebtIssuanceCosts
12300
CY2023Q3 cbdy Debt Issuance Costs
DebtIssuanceCosts
12509
cbdy Debt Issuance Costs
DebtIssuanceCosts
36860
cbdy Debt Issuance Costs
DebtIssuanceCosts
37266
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-291169
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-300309
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-829983
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
369235
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-528950
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-356812
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-55454
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-138705
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-528950
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-356812
us-gaap Net Income Loss
NetIncomeLoss
-55454
us-gaap Net Income Loss
NetIncomeLoss
-138705
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-71160
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
67911
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
31490
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-157070
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-600110
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-288901
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23964
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-295775
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0009
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0009
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0006
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0006
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0001
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0001
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0002
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0002
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
617025999
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
617025999
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
617025999
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
617025999
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-6396551
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-528950
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-71160
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-6996661
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-6566588
CY2023Q3 cbdy Shares To Be Issued As Compensation To Intellectual Property Rights Value
SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue
99
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-356812
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
67911
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6855390
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-6972697
us-gaap Net Income Loss
NetIncomeLoss
-55454
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
31490
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-6996661
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6559825
cbdy Shares To Be Issued As Compensation To Intellectual Property Rights Value
SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue
210
us-gaap Net Income Loss
NetIncomeLoss
-138705
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-157070
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6855390
us-gaap Profit Loss
ProfitLoss
-55454
us-gaap Profit Loss
ProfitLoss
-138705
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-14
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-10314
cbdy Gain Loss On Settlement Of Liability
GainLossOnSettlementOfLiability
36758
cbdy Gain Loss On Settlement Of Liability
GainLossOnSettlementOfLiability
1428185
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
821
cbdy Allowance For Sales Tax Recoverable
AllowanceForSalesTaxRecoverable
11558
cbdy Allowance For Sales Tax Recoverable
AllowanceForSalesTaxRecoverable
7868
us-gaap Depreciation And Amortization
DepreciationAndAmortization
646290
us-gaap Depreciation And Amortization
DepreciationAndAmortization
680043
us-gaap Operating Lease Expense
OperatingLeaseExpense
152833
us-gaap Operating Lease Expense
OperatingLeaseExpense
178134
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
24152
cbdy Debt Issuance Costs
DebtIssuanceCosts
36860
cbdy Debt Issuance Costs
DebtIssuanceCosts
37266
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-957136
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
126802
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-53738
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-179655
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
116135
cbdy Increase Decrease In Sales Tax Recoverable
IncreaseDecreaseInSalesTaxRecoverable
-119242
cbdy Increase Decrease In Sales Tax Recoverable
IncreaseDecreaseInSalesTaxRecoverable
-93043
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-127491
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
390256
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-240980
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-241224
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
8796
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1426247
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-879280
cbdy Payments For Proceeds From Property Plant And Equipment
PaymentsForProceedsFromPropertyPlantAndEquipment
62719
cbdy Payments For Proceeds From Property Plant And Equipment
PaymentsForProceedsFromPropertyPlantAndEquipment
5363
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-440361
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
102923
cbdy Proceeds From Recoverable Expense
ProceedsFromRecoverableExpense
36758
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-128884
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
434998
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
668940
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
735167
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-735167
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
668940
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
562196
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
224658
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-14215
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-3069
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
745019
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
232333
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1293000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
453922
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
120
us-gaap Interest Paid Net
InterestPaidNet
939805
us-gaap Interest Paid Net
InterestPaidNet
874518
CY2024Q3 us-gaap Area Of Land
AreaOfLand
44000
cbdy Settlement Liabilities Current And Noncurrent
SettlementLiabilitiesCurrentAndNoncurrent
0
CY2024Q3 cbdy Working Capital Deficit
WorkingCapitalDeficit
10900226
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31162802
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The preparation of the unaudited condensed consolidated interim financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated interim financial statements and the reported amounts of revenues and expenses during the reporting periods. Estimates may include those pertaining to accruals. Actual results could differ from those estimates.</span></p>
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4736055
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1805211
cbdy Revenue From Investments In Joint Venture
RevenueFromInvestmentsInJointVenture
791285
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
53798
CY2024Q3 us-gaap Inventory Net
InventoryNet
1010292
CY2023Q3 us-gaap Inventory Net
InventoryNet
1892739
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
540053
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
470239
CY2024Q3 us-gaap Inventory Net
InventoryNet
1010292
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
103712
CY2024Q3 cbdy Financing Receivable Interest Rate Stated Percentage
FinancingReceivableInterestRateStatedPercentage
0.5999
CY2024Q3 cbdy Financing Receivable Term
FinancingReceivableTerm
P6M
CY2024Q3 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
103712
CY2024Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
8864
CY2024Q3 cbdy Allowance On Value Added Tax Recoverable
AllowanceOnValueAddedTaxRecoverable
11646
CY2023Q4 cbdy Allowance On Value Added Tax Recoverable
AllowanceOnValueAddedTaxRecoverable
0
CY2017Q3 us-gaap Area Of Land
AreaOfLand
44000
CY2019Q2 us-gaap Area Of Land
AreaOfLand
44000
CY2024Q3 cbdy Depreciation Of Joint Venture Consolidated
DepreciationOfJointVentureConsolidated
22842
CY2023Q3 cbdy Depreciation Of Joint Venture Consolidated
DepreciationOfJointVentureConsolidated
38489
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9047803
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4361497
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4686306
CY2024Q3 cbdy Equity Method Investments Joint Venture
EquityMethodInvestmentsJointVenture
1023608
CY2024Q3 cbdy Receivables From Joint Venture
ReceivablesFromJointVenture
698645
CY2024Q3 cbdy Payable To Joint Venture
PayableToJointVenture
-129185
CY2024Q3 cbdy Gross Investment In Joint Venture
GrossInvestmentInJointVenture
1593068
us-gaap Proceeds From Divestiture Of Interest In Joint Venture
ProceedsFromDivestitureOfInterestInJointVenture
776382
CY2024Q3 cbdy Net Amount Of Investment In Joint Venture
NetAmountOfInvestmentInJointVenture
816686
cbdy Asset Acquired Fair Value Of Accounts Receivables Joint Venture
AssetAcquiredFairValueOfAccountsReceivablesJointVenture
163244
cbdy Asset Acquired Fair Value Of Inventory Joint Venture
AssetAcquiredFairValueOfInventoryJointVenture
1690368
cbdy Asset Acquired Fair Value Of Fixed Assets Joint Venture
AssetAcquiredFairValueOfFixedAssetsJointVenture
534816
cbdy Asset Acquired Fair Value Joint Venture
AssetAcquiredFairValueJointVenture
2388428
cbdy Gain Loss Net On Consolidation Of Joint Venture
GainLossNetOnConsolidationOfJointVenture
1571742
CY2023Q2 cbdy Equity Method Investments Joint Venture
EquityMethodInvestmentsJointVenture
1023608
CY2023Q2 cbdy Receivables From Joint Venture
ReceivablesFromJointVenture
706598
CY2023Q2 cbdy Proceeds From Joint Venture
ProceedsFromJointVenture
776382
CY2023Q2 cbdy Investment In Joint Venture Balance
InvestmentInJointVentureBalance
953824
CY2023Q2 cbdy Gain From Termination Of Joint Venture
GainFromTerminationOfJointVenture
1571742
CY2018Q2 cbdy Business Acquisition Equity Interest Issuable Percentage
BusinessAcquisitionEquityInterestIssuablePercentage
0.4627
CY2024Q3 cbdy Class Of Warrant Or Right Warrants Exercised During Period
ClassOfWarrantOrRightWarrantsExercisedDuringPeriod
0
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
929988
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
6791020
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
7721008
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
7721008
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
43355
CY2024Q3 cbdy Accrued Interest Converted Into Principal
AccruedInterestConvertedIntoPrincipal
657540
CY2024Q3 cbdy Accrued Interest Converted Into Principal
AccruedInterestConvertedIntoPrincipal
900000
CY2024Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2886380
CY2024Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2138231
CY2024Q3 us-gaap Line Of Credit
LineOfCredit
2786380
CY2024Q3 us-gaap Line Of Credit
LineOfCredit
2064151
us-gaap Line Of Credit Facility Periodic Payment Interest
LineOfCreditFacilityPeriodicPaymentInterest
587518
us-gaap Line Of Credit Facility Periodic Payment Interest
LineOfCreditFacilityPeriodicPaymentInterest
799163
CY2024Q3 cbdy Line Of Credit Facility Accrued Interest
LineOfCreditFacilityAccruedInterest
592020
CY2024Q3 cbdy Line Of Credit Facility Accrued Interest
LineOfCreditFacilityAccruedInterest
799163
cbdy Number Of Operating Lease Facilities
NumberOfOperatingLeaseFacilities
2
CY2024Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.16
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
80942
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
327007
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
330277
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
333580
CY2024Q3 cbdy Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
791764
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1863570
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
631434
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1232136
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
142943
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1089193
CY2024Q3 cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
102209
CY2023Q3 cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
58375
cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
152833
cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
178134
CY2024Q3 cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
-45923
CY2023Q3 cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
61354
cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
13063
cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
244560
cbdy Recoverable Expenses From Jv Co Related To Rent And Utilities
RecoverableExpensesFromJvCoRelatedToRentAndUtilities
285655
CY2024Q3 cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
56286
CY2023Q3 cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
119729
cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
165896
cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
137039
us-gaap Interest Expense Debt
InterestExpenseDebt
9
us-gaap Interest Expense Debt
InterestExpenseDebt
10
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
8021
cbdy Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
-47
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
7974
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
617025999
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
617025999
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
100
cbdy Schedule Of Shares To Be Issued
ScheduleOfSharesToBeIssued
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:47.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Description</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">80,000 shares of common stock to be issued as compensation to advisers and consultants. These were recorded at fair value of $52,000, based on the market price of the Company’s stock on the date of issue.</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 115,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 73,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">35,000 to be issued as settlement of the amount due for website development services amounting to $247,306. The fair value of the shares on the date of settlement was $21,000, resulting in a gain on settlement amounting to $226,306 during the year ended December 31, 2017.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Private placements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 346,296</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,787</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Consideration for private placements with the fair value based on cash proceeds received. Proper allocation between common stock and additional paid-in capital of the amount received will be completed in the period when the shares are issued.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Settlement of loans of CannaKorp</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 930,240</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 80,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Refer to Note 10 for details.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Agreement with Serious Seeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 249,984</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,814</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">As consideration for intellectual property rights granted by Smit. The fair value is based on the market price of the Company’s stock on the date of issue as per the agreement.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,641,520</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 175,439</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr></table>
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
115000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
73000
CY2024Q3 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2024Q1 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2024Q2 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2024Q1 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
4.76
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
4.61
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
4.33
CY2024Q3 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2024Q1 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q3 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
119
CY2024Q2 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
173
CY2024Q1 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
134
CY2023Q4 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2023Q3 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2023Q2 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2023Q1 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.300
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
4.38
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.99
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.42
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.05
CY2023Q4 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2023Q3 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2023Q2 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2023Q1 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q4 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
158
CY2023Q3 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
313
CY2023Q2 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
138
CY2023Q1 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
160
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10400008
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10400008
cbdy Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
0
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
355
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
426
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-367
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
414
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1379966
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1862805
CY2024Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
10885
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001410578-24-001793-index-headers.html Edgar Link pending
0001410578-24-001793-index.html Edgar Link pending
0001410578-24-001793.txt Edgar Link pending
0001410578-24-001793-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20240930.xsd Edgar Link pending
tmb-20240930x10q.htm Edgar Link pending
tmb-20240930xex10d36.htm Edgar Link pending
tmb-20240930xex31d1.htm Edgar Link pending
tmb-20240930xex31d2.htm Edgar Link pending
tmb-20240930xex32d1.htm Edgar Link pending
tmb-20240930_def.xml Edgar Link unprocessable
tmb-20240930_lab.xml Edgar Link unprocessable
tmb-20240930_pre.xml Edgar Link unprocessable
tmb-20240930x10q_htm.xml Edgar Link completed
tmb-20240930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable